688098 申联生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)0.020-3.0852.1114.1077.665
总资产报酬率 ROA (%)0.018-2.8421.9703.8157.080
投入资产回报率 ROIC (%)0.019-3.0432.0984.0797.603

边际利润分析
销售毛利率 (%)59.49460.24970.83375.22975.731
营业利润率 (%)-1.098-18.62511.98022.89635.903
息税前利润/营业总收入 (%)-0.573-18.96011.72122.39834.704
净利润/营业总收入 (%)-1.272-16.0679.90118.55629.144

收益指标分析
经营活动净收益/利润总额(%)-177.77445.93685.004103.27990.138
价值变动净收益/利润总额(%)-39.446-4.70015.9604.4429.590
营业外收支净额/利润总额(%)-93.6110.4990.403-0.917-2.148

偿债能力分析
流动比率 (X)4.2734.7407.8207.2576.461
速动比率 (X)3.6413.9226.3596.0715.550
资产负债率 (%)8.9358.2685.4536.7427.850
带息债务/全部投入资本 (%)1.1451.436-0.1680.018-0.191
股东权益/带息债务 (%)8,561.6616,802.656-59,367.630540,213.360-51,981.356
股东权益/负债合计 (%)1,011.2771,098.3231,712.6371,383.2681,178.606
利息保障倍数 (X)100.46078.353-38.060-77.237-78.109

营运能力分析
应收账款周转天数 (天)333.225317.608296.208204.417141.782
存货周转天数 (天)246.869308.764464.908483.748361.281